Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy

Clicks: 600
ID: 118797
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The urokinase-type plasminogen activator (uPA) receptor (uPAR) participates to the mechanisms causing renal damage in response to hyperglycaemia. The main function of uPAR in podocytes (as well as soluble uPAR -(s)uPAR- from circulation) is to regulate podocyte function through αvβ3 integrin/Rac-1. …
Reference Key
m2019journalinhibiting Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dal Monte M;Cammalleri M;Pecci V;Carmosino M;Procino G;Pini A;De Rosa M;Pavone V;Svelto M;Bagnoli P;;
Journal Journal of cellular and molecular medicine
Year 2019
DOI
DOI not found
URL
https://www.pubmed.gov/30426662/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE animals pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't male Rats Sprague-Dawley Receptors signal transduction / physiology diabetes mellitus massimo dal monte inflammation / metabolism up-regulation / physiology maurizio cammalleri paola bagnoli pmid:30426662 pmc6349167 doi:10.1111/jcmm.14004 experimental / chemically induced experimental / metabolism* diabetic nephropathies / chemically induced* diabetic nephropathies / metabolism* kidney / metabolism podocytes / metabolism urokinase plasminogen activator / metabolism* streptozocin / pharmacology* urokinase-type plasminogen activator / metabolism

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.